Association Between Liver Function Tests and Acute Kidney Injury in Cardiac Surgery Patients
TransAKI
Association Between Elevated Liver Functions Tests Following Cardiac Surgery and Acute Kidney Injury - a Restrospectiv Single Center Cohort Study
TransAKI
Association Between Elevated Liver Functions Tests Following Cardiac Surgery and Acute Kidney Injury - a Restrospectiv Single Center Cohort Study
Sponsor study identifier
observational
3,415
1 country
1
Study Start
November 6, 2024
Actual (reported)Primary Completion
November 6, 2024
Actual (reported)Study Completion
November 6, 2024
Actual (reported)A sudden decline in function of the kidneys is a common problem that can happen after heart surgery. It can have serious effects on a patient's recovery and long-term health, potentially leading to permanent kidney problems or heart-related issues. One of the main reasons kidney problems occurs is due to changes in blood flow caused by the heart not pumping well enough. These changes may harm the kidneys, but other organs as well such as the liver. This study aims to find out if there is a relationship between elevated levels of liver function blood tests and the decline in kidney function.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 6, 2024
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 6, 2024
Actual (reported)November 6, 2024
Actual (reported)November 6, 2024
Actual (reported)November 26, 2024
Actual (reported)December 12, 2024
Actual (reported)Association between liver enzymes and acute kidney injury
Investigation of the association between liver enzymes (alanine aminotransferase (AST); aspartate aminotransferase (ALT)) and development of acute kidney injury. Data about liver enzymes will be collected at ICU admission, and 12 hours and 24 hours after ICU admission. AKI is defined by the Kidney Disease Improving global outcome definition by using both the serum creatinine and urine output criteria.
Data about liver enzymes will be collected at ICU admission, and 12 hours and 24 hours after ICU admission. The occurrence of acute kidney injury within 72 hours after ICU admission will be investigated
Association between liver enzymes and the severity of acute kidney injury
Data about liver enzymes will be collected at ICU admission, and 12 hours and 24 hours after ICU admission. The occurrence of the different severity stages of acute kidney injury within 72 hours after ICU admission will be investigated
association of central venous pressure with elevated liver enzymes and acute kidney injury
Data about central venous pressure will be collected during the first 24 hours after ICU admission.
In the included patients the occurrence of acute kidney injury (AKI) will be investigated. So patient will be grouped as 'no AKI' and 'AKI' For the subanalysis, patient will be grouped according to their admission central venous pressure. There are no interventions.
The cardiac surgery patients screened for eligibility were admitted on the cardiac surgery intensive care unit of Ghent University hospital between 1 Januari 2012 until 31 december 2017
Ghent university hospital
Ghent, Oost-Vlaanderen, 9000, Belgium
Wim Vandenberghe, MD; PhD
University Hospital, Ghent
3,415 participants (actual enrollment reported by the registry).
First Submitted
November 26, 2024
First Posted
December 12, 2024
Study Start
November 6, 2024
Actual (reported)Metabolic Complications Using a Low- Versus High Concentration Citrate Solution for Regional Anticoagulation in Continuous Kidney Replacement Therapy: A Pragmatic Randomized Trial.
Contact the study team to confirm eligibility.
Primary Completion
November 6, 2024
Actual (reported)Study Completion
November 6, 2024
Actual (reported)Last Updated
December 12, 2024
Record last verified: 2024-11
Due to European Data Protection regulation, no individual participant data will be shared, only the analysed data.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: